EUCTR2015-003220-31-NL进行中（未招募）1 期
ow dose aspirin in the Prevention of Recurrent Spontaneous Preterm Labour – the APRIL study
VU medical center, Amsterdam0 个研究点目标入组 406 人开始时间: 2016年3月16日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 406
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •Pregnant women: >18 years old on inclusion, with a history of spontaneous preterm birth.
- •Spontaneous preterm birth is defined as: birth following spontaneous contractions with intact membranes or birth after preterm ruptured membranes at a gestational age between 22 and 37 weeks. .
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 406
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- History of Indicated PTB for maternal reasons such as preeclampsia or HELLP
- •- History of indicated PTB fetal reasons such as IUGR
- •- Fetal abnormalities
- •- Multiple pregnancy either in index or current pregnancy
研究者
相似试验
已完成
3 期
ow dose aspirin in the Prevention of Recurrent Spontaneous Preterm LabourNL-OMON47921Vrije Universiteit Medisch Centrum406
招募中
不适用
STUDY ON THE ROLE OF ASPIRIN IN PREVENTING PRETERM BIRTHCTRI/2021/03/031734PGIMER
已完成
3 期
The use of low-dose aspirin for the prevention of hypertensive disorders of pregnancy in a Sub-Saharan countryPrevention of hypertensive disorders of pregnancy, in particular, pre-eclampsiaPregnancy and ChildbirthISRCTN43031232niversity of KwaZulu-Natal423
已完成
2 期
Efficiency of low dose aspirin for prevention of complications for in vitro fertilization cycles of the patient with polycystic ovarian syndromepolycystic ovarian syndrome.Polycystic ovarian syndromeIRCT201105216541N1Infertility research center, Shiraz university of Medical Sciences80
已完成
不适用
sing of aspirin in the prevention of preeclampsiaCondition 1: Preeclampsia. Condition 2: preeclampsia.Gestational [pregnancy-induced] hypertension with significant proteinuria??? ???????? ????-??? ???????? ????-??? ???????? ?? ????? ??? ???????O14.0,O14.IRCT2013072914198N1Mazandaran University of Medical Sciences100